Eleison Pharmaceuticals Inc — Form C-U (Regulation Crowdfunding)
Eleison Pharmaceuticals Inc of PRINCETON, NJ filed a Form C-U (Regulation Crowdfunding) with the SEC on 2025-04-16. Target raise $124K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-04-16
- Form: C-U
- Accession: 0001665160-25-000687
- Target amount: $124K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 124,000
- Deadline: 2025-04-09
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0001880047
- Website: www.eleison-pharma.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2009-10-14
- Address: 100 OVERLOOK CENTER, 2ND FLOOR, PRINCETON, NJ, 08540
- Employees: 5
Financials (as filed)
- Total assets (most recent): $729K
- Cash (most recent): $10K
- Net income (most recent): $-2.6M
- Net income (prior): $-4.7M
- Short-term debt: $3.3M
- Long-term debt: $2.5M
People (3)
| Name | Role | Location |
|---|
| Joel Morganroth | Board Member | Sarasota, FL |
| Edwin J. Thomas | CEO, Principal Accounting Officer, and Board Member | PRINCETON, NJ |
| Michael Otto | Board Member | PRINCETON, NJ |
Reg CF filing history (2)
More